---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-007964"
form_type: "8-K"
ticker: "BLFS"
cik: "0000834365"
company_name: "BIOLIFE SOLUTIONS INC"
filed_at: "2024-02-29T23:59:59+00:00"
generated_at: "2026-06-05T07:38:29.625240+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BioLife Q4 rev $32.7M (-26% YoY); guides 2024 rev $95.5-100M ex-freezer; adj EBITDA positive

## Summary
- Q4 GAAP net loss $13.4M ($0.30 loss/share) vs $49.2M loss ($1.15) in Q4 2022.
- Cell Processing platform Q4 rev $14.8M, down 27% YoY but up 11% sequentially.
- Freezer divestiture underway; expects sale by end of Q1 2024.
- 2024 revenue guidance $95.5-100.0M (ex-freezer); expects full-year positive adjusted EBITDA.
- Biopreservation media embedded in 14 approved CGT therapies as of Feb 2024.

## SEC filing metadata
- accession: 0001628280-24-007964
- form_type: 8-K
- ticker: BLFS
- cik: 0000834365
- company_name: BIOLIFE SOLUTIONS INC
- filed_at: 2024-02-29T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/834365/000162828024007964/0001628280-24-007964-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/834365/000162828024007964/blfs-20240229.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-007964
- JSON: https://secwatch.observer/filing/0001628280-24-007964.json
- Plain text: https://secwatch.observer/filing/0001628280-24-007964.txt

## Key facts
- Earnings Releases
  BIOLIFE SOLUTIONS INC updated its the fourth quarter and year ended December 31, 2023 guidance (initiated).
  - Period: the fourth quarter and year ended December 31, 2023
  - Guidance: initiated
  - Result: reported results
  source text: On February 29, 2024, BioLife Solutions, Inc., a Delaware corporation, issued a press release announcing financial results and operational highlights for the fourth quarter and year ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/834365/000162828024007964/0001628280-24-007964-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.